Where I see patients (1)
Selected research
-
Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial.
Journal of the American Academy of Dermatology
-
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
JAMA dermatology
-
Comparison of large language models in generating patient handouts for the dermatology clinic: A blinded study.
JAAD international